← Back to catalogue

ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test

FDA UDIEUDAMED

Class N (US FDA UDI)

by Lumos Diagnostics, Inc.

Identity

Trade Name
ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test FDA UDI
Generic Name
SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical FDA UDI
Device Name
ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test Kit, 25 tests FDA UDI
Model / Reference
CP0031 FDA UDI
Description
ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test Kit, 25 tests FDA UDI

Identifiers

Catalog Number
CP0031 FDA UDI
Primary DI / UDI-DI
00850056728706 FDA UDI
FDA Product Code
QKP FDA UDI
PSZ FDA UDI
GMDN Term
SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
N FDA UDI
Regulation Number
866.3328 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: SARS-CoV-2 antigen IVD, kit, rapid ICT, clinicalInfluenza A/B virus antigen IVD, kit, rapid ICT, clinical

ViraDx™ SARS-CoV-2/Flu A+B Rapid Antigen Test by Lumos Diagnostics, Inc. — Class N — IVDD, FDA UDI — listed in FDA GUDID, EUDAMED — regulatory data on deviCERTS

Similar devices

Also classified as Influenza A/B virus antigen IVD, kit, rapid ICT, clinical.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Unknown

IVDD

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA UDI 2767cbe2-93f7-47d4-bb6c-e350ae127d59 36 fields · synced Jun 17, 2026
  • EUDAMED 1 fields · synced Jun 4, 2026